Diagnostic imaging using positron emission tomography for gynecological malignancy
Imaging has played a pivotal role in the management of gynecological malignancy. Positron emission tomography (PET), particularly 18F‐fluorodeoxyglucose (18F‐FDG) PET to reflect cellular glycolytic metabolism, is being increasingly used and has proven superior to conventional imaging including ultra...
Gespeichert in:
| Veröffentlicht in: | The journal of obstetrics and gynaecology research 2017-11, Vol.43 (11), p.1687-1699 |
|---|---|
| Hauptverfasser: | , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 1699 |
|---|---|
| container_issue | 11 |
| container_start_page | 1687 |
| container_title | The journal of obstetrics and gynaecology research |
| container_volume | 43 |
| creator | Tsuyoshi, Hideaki Yoshida, Yoshio |
| description | Imaging has played a pivotal role in the management of gynecological malignancy. Positron emission tomography (PET), particularly 18F‐fluorodeoxyglucose (18F‐FDG) PET to reflect cellular glycolytic metabolism, is being increasingly used and has proven superior to conventional imaging including ultrasonography, computed tomography (CT), and magnetic resonance imaging. Studies of and evidence for the utility of 18F‐FDG PET/CT for the detection of local or metastatic disease, treatment planning, response assessment, restaging of recurrent disease, and prognostic assessment are growing. We review the latest evidence for and limitations of 18F‐FDG PET/CT in the diagnosis of gynecological malignancy. Moreover, we also describe the benefits of and evidence for other tracers. |
| doi_str_mv | 10.1111/jog.13436 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1937524060</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1958469452</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4786-b47ecddbb517fda618c7a0f09a23e80aed422aa9581f61867587377cf4bfdd6c3</originalsourceid><addsrcrecordid>eNp1kE9LxDAQxYMo7vrn4BeQghc9dDdp0yQ9yqqrsrAgei5pmsQsbbMmLdJvb9auHgTnMPNgfvMYHgAXCM5QqPnG6hlKcUoOwBRhTGNIM3IYdIpRzCAlE3Di_QZCRHPEjsEkYYxhxtIpeLkzXLfWd0ZEpuHatDrq_a5vrTeds20kG-O9CaKzjdWOb9-HSFkX6aGVwtZWG8HrqOG10S1vxXAGjhSvvTzfz1Pw9nD_uniMV-vl0-J2FQtMGYlLTKWoqrLMEFUVJ4gJyqGCOU9SySCXFU4SzvOMIRWWhGaMppQKhUtVVUSkp-B69N06-9FL3xXhUSHrmrfS9r5AeUqzBEMCA3r1B93Y3rXhu0BlDJMcZ0mgbkZKOOu9k6rYupCJGwoEi13Q4UoX30EH9nLv2JeNrH7Jn2QDMB-BT1PL4X-n4nm9HC2_AHU9iJA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1958469452</pqid></control><display><type>article</type><title>Diagnostic imaging using positron emission tomography for gynecological malignancy</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Tsuyoshi, Hideaki ; Yoshida, Yoshio</creator><creatorcontrib>Tsuyoshi, Hideaki ; Yoshida, Yoshio</creatorcontrib><description>Imaging has played a pivotal role in the management of gynecological malignancy. Positron emission tomography (PET), particularly 18F‐fluorodeoxyglucose (18F‐FDG) PET to reflect cellular glycolytic metabolism, is being increasingly used and has proven superior to conventional imaging including ultrasonography, computed tomography (CT), and magnetic resonance imaging. Studies of and evidence for the utility of 18F‐FDG PET/CT for the detection of local or metastatic disease, treatment planning, response assessment, restaging of recurrent disease, and prognostic assessment are growing. We review the latest evidence for and limitations of 18F‐FDG PET/CT in the diagnosis of gynecological malignancy. Moreover, we also describe the benefits of and evidence for other tracers.</description><identifier>ISSN: 1341-8076</identifier><identifier>EISSN: 1447-0756</identifier><identifier>DOI: 10.1111/jog.13436</identifier><identifier>PMID: 28884883</identifier><language>eng</language><publisher>Australia: Wiley Subscription Services, Inc</publisher><subject>18F‐fluorodeoxyglucose ; Computed tomography ; Female ; Genital Neoplasms, Female - diagnostic imaging ; Glycolysis ; Gynecological cancer ; gynecological malignancy ; Gynecology ; Humans ; Magnetic resonance imaging ; Malignancy ; Medical imaging ; Metastases ; Positron emission tomography ; Positron Emission Tomography Computed Tomography - methods ; Tomography ; Tracers ; Ultrasound</subject><ispartof>The journal of obstetrics and gynaecology research, 2017-11, Vol.43 (11), p.1687-1699</ispartof><rights>2017 Japan Society of Obstetrics and Gynecology</rights><rights>2017 Japan Society of Obstetrics and Gynecology.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4786-b47ecddbb517fda618c7a0f09a23e80aed422aa9581f61867587377cf4bfdd6c3</citedby><cites>FETCH-LOGICAL-c4786-b47ecddbb517fda618c7a0f09a23e80aed422aa9581f61867587377cf4bfdd6c3</cites><orcidid>0000-0003-0769-0385</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fjog.13436$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fjog.13436$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28884883$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Tsuyoshi, Hideaki</creatorcontrib><creatorcontrib>Yoshida, Yoshio</creatorcontrib><title>Diagnostic imaging using positron emission tomography for gynecological malignancy</title><title>The journal of obstetrics and gynaecology research</title><addtitle>J Obstet Gynaecol Res</addtitle><description>Imaging has played a pivotal role in the management of gynecological malignancy. Positron emission tomography (PET), particularly 18F‐fluorodeoxyglucose (18F‐FDG) PET to reflect cellular glycolytic metabolism, is being increasingly used and has proven superior to conventional imaging including ultrasonography, computed tomography (CT), and magnetic resonance imaging. Studies of and evidence for the utility of 18F‐FDG PET/CT for the detection of local or metastatic disease, treatment planning, response assessment, restaging of recurrent disease, and prognostic assessment are growing. We review the latest evidence for and limitations of 18F‐FDG PET/CT in the diagnosis of gynecological malignancy. Moreover, we also describe the benefits of and evidence for other tracers.</description><subject>18F‐fluorodeoxyglucose</subject><subject>Computed tomography</subject><subject>Female</subject><subject>Genital Neoplasms, Female - diagnostic imaging</subject><subject>Glycolysis</subject><subject>Gynecological cancer</subject><subject>gynecological malignancy</subject><subject>Gynecology</subject><subject>Humans</subject><subject>Magnetic resonance imaging</subject><subject>Malignancy</subject><subject>Medical imaging</subject><subject>Metastases</subject><subject>Positron emission tomography</subject><subject>Positron Emission Tomography Computed Tomography - methods</subject><subject>Tomography</subject><subject>Tracers</subject><subject>Ultrasound</subject><issn>1341-8076</issn><issn>1447-0756</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kE9LxDAQxYMo7vrn4BeQghc9dDdp0yQ9yqqrsrAgei5pmsQsbbMmLdJvb9auHgTnMPNgfvMYHgAXCM5QqPnG6hlKcUoOwBRhTGNIM3IYdIpRzCAlE3Di_QZCRHPEjsEkYYxhxtIpeLkzXLfWd0ZEpuHatDrq_a5vrTeds20kG-O9CaKzjdWOb9-HSFkX6aGVwtZWG8HrqOG10S1vxXAGjhSvvTzfz1Pw9nD_uniMV-vl0-J2FQtMGYlLTKWoqrLMEFUVJ4gJyqGCOU9SySCXFU4SzvOMIRWWhGaMppQKhUtVVUSkp-B69N06-9FL3xXhUSHrmrfS9r5AeUqzBEMCA3r1B93Y3rXhu0BlDJMcZ0mgbkZKOOu9k6rYupCJGwoEi13Q4UoX30EH9nLv2JeNrH7Jn2QDMB-BT1PL4X-n4nm9HC2_AHU9iJA</recordid><startdate>201711</startdate><enddate>201711</enddate><creator>Tsuyoshi, Hideaki</creator><creator>Yoshida, Yoshio</creator><general>Wiley Subscription Services, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>7TO</scope><scope>H94</scope><scope>K9.</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-0769-0385</orcidid></search><sort><creationdate>201711</creationdate><title>Diagnostic imaging using positron emission tomography for gynecological malignancy</title><author>Tsuyoshi, Hideaki ; Yoshida, Yoshio</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4786-b47ecddbb517fda618c7a0f09a23e80aed422aa9581f61867587377cf4bfdd6c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>18F‐fluorodeoxyglucose</topic><topic>Computed tomography</topic><topic>Female</topic><topic>Genital Neoplasms, Female - diagnostic imaging</topic><topic>Glycolysis</topic><topic>Gynecological cancer</topic><topic>gynecological malignancy</topic><topic>Gynecology</topic><topic>Humans</topic><topic>Magnetic resonance imaging</topic><topic>Malignancy</topic><topic>Medical imaging</topic><topic>Metastases</topic><topic>Positron emission tomography</topic><topic>Positron Emission Tomography Computed Tomography - methods</topic><topic>Tomography</topic><topic>Tracers</topic><topic>Ultrasound</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Tsuyoshi, Hideaki</creatorcontrib><creatorcontrib>Yoshida, Yoshio</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><jtitle>The journal of obstetrics and gynaecology research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Tsuyoshi, Hideaki</au><au>Yoshida, Yoshio</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Diagnostic imaging using positron emission tomography for gynecological malignancy</atitle><jtitle>The journal of obstetrics and gynaecology research</jtitle><addtitle>J Obstet Gynaecol Res</addtitle><date>2017-11</date><risdate>2017</risdate><volume>43</volume><issue>11</issue><spage>1687</spage><epage>1699</epage><pages>1687-1699</pages><issn>1341-8076</issn><eissn>1447-0756</eissn><abstract>Imaging has played a pivotal role in the management of gynecological malignancy. Positron emission tomography (PET), particularly 18F‐fluorodeoxyglucose (18F‐FDG) PET to reflect cellular glycolytic metabolism, is being increasingly used and has proven superior to conventional imaging including ultrasonography, computed tomography (CT), and magnetic resonance imaging. Studies of and evidence for the utility of 18F‐FDG PET/CT for the detection of local or metastatic disease, treatment planning, response assessment, restaging of recurrent disease, and prognostic assessment are growing. We review the latest evidence for and limitations of 18F‐FDG PET/CT in the diagnosis of gynecological malignancy. Moreover, we also describe the benefits of and evidence for other tracers.</abstract><cop>Australia</cop><pub>Wiley Subscription Services, Inc</pub><pmid>28884883</pmid><doi>10.1111/jog.13436</doi><tpages>13</tpages><orcidid>https://orcid.org/0000-0003-0769-0385</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1341-8076 |
| ispartof | The journal of obstetrics and gynaecology research, 2017-11, Vol.43 (11), p.1687-1699 |
| issn | 1341-8076 1447-0756 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_1937524060 |
| source | MEDLINE; Wiley Online Library Journals Frontfile Complete |
| subjects | 18F‐fluorodeoxyglucose Computed tomography Female Genital Neoplasms, Female - diagnostic imaging Glycolysis Gynecological cancer gynecological malignancy Gynecology Humans Magnetic resonance imaging Malignancy Medical imaging Metastases Positron emission tomography Positron Emission Tomography Computed Tomography - methods Tomography Tracers Ultrasound |
| title | Diagnostic imaging using positron emission tomography for gynecological malignancy |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-20T21%3A31%3A41IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Diagnostic%20imaging%20using%20positron%20emission%20tomography%20for%20gynecological%20malignancy&rft.jtitle=The%20journal%20of%20obstetrics%20and%20gynaecology%20research&rft.au=Tsuyoshi,%20Hideaki&rft.date=2017-11&rft.volume=43&rft.issue=11&rft.spage=1687&rft.epage=1699&rft.pages=1687-1699&rft.issn=1341-8076&rft.eissn=1447-0756&rft_id=info:doi/10.1111/jog.13436&rft_dat=%3Cproquest_cross%3E1958469452%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1958469452&rft_id=info:pmid/28884883&rfr_iscdi=true |